| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $416.4K | - | |
| CFO | 26.0K | $180.4K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2016 | Valone Frank H Md | Chief Medical Officer | Sale+OE | 10,750 | $18.41 | $197,942.98 | -10.0% | |
| Feb 10, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $15.31 | $413,360.00 | -0.2% | |
| Jan 29, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $19.41 | $524,015.00 | -0.2% | |
| Jan 21, 2016 | Kearns Thomas F Jr | Director | Sell | 1,572 | $22.08 | $34,709.76 | -1.0% | |
| Jan 14, 2016 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $23.69 | $639,683.00 | -0.2% | |
| Dec 24, 2015 | Kearns Thomas F Jr | Director | Sell | 7,800 | $30.88 | $240,825.00 | -2.3% | |
| Dec 23, 2015 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $30.10 | $812,703.00 | -0.2% | |
| Dec 15, 2015 | Cotroneo Pat | VP, Finance And CFO | Sell | 837 | $28.95 | $24,231.15 | -0.8% | |
| Dec 11, 2015 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $29.59 | $798,815.00 | -0.2% | |
| Dec 10, 2015 | Yu K Peony | VP, Clinical Development | Sell | 1,093 | $28.96 | $31,653.28 | -0.6% |